Sangamo Biosciences (SGMO) Tops Q4 EPS by 11c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -5.7%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q4 EPS of ($0.14), $0.11 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $3.91 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
- Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
